Sunday, October 11, 2026

Pfizer Stock Bullish Momentum With A 4.54% Rise At Session Start On Tuesday

ViaNews Editorial Team

December 1, 2020

Pfizer Stock Bullish Momentum With A 4.54% Rise At Session Start On Tuesday

According to today's article on Bloomberg Quint, "Pfizer, BioNTech Seek Clearance to Sell Covid Vaccine in Europe."

Pfizer, biontech seek EU clearance for covid-19 vaccine. According to today's article on Bloomberg Quint, "Pfizer Inc"

Pfizer-biontech seeks EU clearance for coronavirus vaccine. According to today's article on ForexLive, "Pfizer vaccine can be in use in the EU by the year-end if cleared Pfizer-BioNTech just announced that they have submitted an application to the EMA today to seek clearance for coronavirus vaccine use in the EU.."

Pfizer, biontech file for covid-19 vaccine approval in europe. According to today's article on The Wall Street Journal, "Pfizer and partner BioNTech said they are seeking approval from the European Union for their coronavirus vaccine.."

Shares of Pfizer jumped 4.54% to $40.05 at 10:12 EST on Tuesday, following yesterday's upward trend. The New York Stock Exchange is falling 1.35% to $14,006.50, following yesterday's downward trend, on what up to now seems, an all-around negative trend trading session today.

Pfizer's last close was $37.23, 0.53% below its 52-week high of $39.84.

Pfizer's sales growth is a negative 9.7% for the current quarter and a decline by 9.1% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 12.7% and a negative 12.5%, respectively.

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.

Pfizer's stock is valued at $40.05 at 10:12 EST, above its 52-week high of $39.84.

Pfizer's worth is way above its 50-day moving average of $35.58 and way above its 200-day moving average of $34.80.

According to Bloomberg Quint on Fri Nov 27, "Malaysia Inks Pact With Pfizer to Vaccinate 6.4 Million Citizens."

Stocks making the biggest moves in the premarket: astrazeneca, disney, Pfizer, Amazon & more. According to CNBC on Fri Nov 27, "The stocks making the biggest moves in premarket trading include AstraZeneca, Disney, Pfizer, Amazon, and more.."

According to Bloomberg Quint on Sat Nov 28, "U.K"

According to Bloomberg Quint on Sat Nov 28, "U.K"

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com